Stryker shrugs off recall charges in Q4 to end 2012 on target
January 24, 2013 by MassDevice staff
Medical device company Stryker Corp. gives back ⅓ of its profits on charges related to the 4th-quarter recall of its Rejuvenate and ABG II modular-neck hip stems, but manages to top analyst estimates nonetheless.
Orthopedic giant Stryker (NYSE:SYK) reported a nearly 33% drop in net income for the 4th quarter on expected charges related to the Rejuvenate and ABG II modular-neck hip stems recall but the company managed to end 2012 strong.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
Navigation
NEWS
EuroPCR: 1-year results continue to support Edwards' next-gen Sapien XT valve
Medical device company Edwards Lifesciences unveils 1-year results for its next-generation Sapien XT...
DePuy Pinnacle lawsuits: Judge orders J&J's DePuy Orthopaedics to produce compliance reports
A federal judge overseeing a raft of cases filed against Johnson & Johnson's DePuy Orthopaedics...
EuroPCR: Boston Scientific's Lotus TAVI bests rivals with less leakage
Medical device giant Boston Scientific touts very low rates of paravalvular leakage in 30-day results...
Medical device tax: LA Times editorial calls repeal efforts "narrow-minded and dishonest"
Efforts to undermine the medical device tax are "narrow-minded and dishonest" attempts to win "...
EuroPCR: Medtronic's CoreValve is a cost-effective option, U.K. researchers say
U.K. researchers report that Medtronic's CoreValve transcatheter aortic valve implantation system is...
